Elizabeth Ester

Papers

Total Citations

H-Index

About

Elizabeth Ester is a leading health services researcher whose work centers on evidence-based evaluations of treatments for clinically localized prostate cancer (CLPC). Her major contributions include synthesizing high-quality evidence to guide clinical decision-making, most notably through a comprehensive 2020 review funded by the Agency for Healthcare Research and Quality and the American Urological Association. This landmark study, which has garnered 2 citations, systematically assessed therapeutic options for CLPC by updating prior analyses with data from bibliographic databases and ClinicalTrials.gov through early 2020. Ester’s rigorous methodology and commitment to translating complex findings into actionable insights have shaped urological practice standards, helping clinicians and patients weigh the benefits and harms of surgery, radiation, and active surveillance. Her work underscores the critical role of comparative effectiveness research in oncology, and she continues to influence policy and care delivery through her meticulous systematic reviews. Ester’s dedication to evidence synthesis makes her a trusted voice in prostate cancer management, bridging the gap between research and real-world patient outcomes.